搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
MassDevice
3 小时
Fractyl Health announces layoffs as it pivots to gene therapy
Fractyl Health (Nasdaq:GUTS) wants to focus more on certain therapies, leading the company to cut nearly a fifth of its ...
MassDevice
6 小时
Surmodics reports first clinical use of thrombectomy system
Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.
MassDevice
7 小时
Activist investors reportedly push BD to sell Life Sciences biz
The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.
MassDevice
8 小时
GE HealthCare invests $138M in Ireland contrast media manufacturing plant
GE HealthCare (Nasdaq: GEHC) announced a $138 million investment to expand its contrast media fill/finish manufacturing site ...
MassDevice
8 小时
Baxter CEO Almeida to retire, Kidney Care business becomes standalone company
Baxter Chair, President and CEO Joe Almeida [Photo courtesy of Baxter] Baxter (NYSE: BAX) + announced today that José (Joe) E ...
MassDevice
3 天
Butterfly Network raising $76.5 million from public offering
Butterfly Network has been expecting gross proceeds of $76.6 million from a public offering slated to close today.
MassDevice
3 天
Beta Bionics goes public with upsized $204M IPO
Beta Bionics announced today that it went public after pricing a significantly upsized initial public offering (IPO).
MassDevice
3 天
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
MassDevice
4 天
Rad AI raises $60M in Series C to bring generative AI to radiology
Rad AI today announced that it's raised a $60 million Series C financing round, valuing the company at $525 million.
MassDevice
4 天
Getinge to phase out its surgical perfusion business
Getinge will gradually phase out its surgical perfusion business, to focus on more profitable growth areas such as ECLS and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈